ADARx Pharmaceuticals
ADARx Pharmaceuticals, Inc. is a clinical-stage biotechnology company headquartered at 5871 Oberlin Drive, San Diego, California, founded in 2019 and developing next-generation RNA therapeutics intended to control the expression of specific disease drivers with highly selective RNA-targeted medicines. Its proprietary platform spans RNA interference, RNA editing and targeted oligonucleotide delivery, engineered around compact, modular constructs the company says extend reach beyond the liver. The clinical pipeline is led by ADX-324 (onvuzosiran), an siRNA against prekallikrein now in the Phase 3 STOP-HAE study in hereditary angioedema, and ADX-038 (agazisiran), an siRNA against complement factor B in Phase 2 for IgA nephropathy and C3 glomerulopathy, geographic atrophy and paroxysmal nocturnal hemoglobinuria; earlier programmes include ADX-626 (factor XI, thrombosis), ADX-077 (obesity) and ADX-199 (amyloid-beta precursor protein, neurodegeneration), plus undisclosed extrahepatic CNS, immunology and oncology work. The company closed an oversubscribed 200 million dollar Series C in August 2023 co-led by Bain Capital Life Sciences and TCGX, and entered a collaboration and license option agreement with AbbVie in May 2025. ADARx runs no developer program and publishes no product API, no developer portal and no API documentation; the only machine-readable surfaces reachable without credentials are the WordPress REST content APIs behind www.adarx.com and stophae.com, both catalogued here.
ADARx Pharmaceuticals publishes 8 APIs on the APIs.io network, including Clinics API, Content API, Embed API, and 5 more. Tagged areas include Company, biotechnology, biopharmaceuticals, rna-therapeutics, and sirna.
The ADARx Pharmaceuticals catalog on APIs.io includes 1 JSON-LD context.
ADARx Pharmaceuticals’ developer surface includes product news, support, authentication, and 30 more developer resources.
Kin Score
APIs 8
Individual APIs this provider publishes, each with its own machine-readable definition.
ADARx Pharmaceuticals Clinics API
The STOP-HAE trial-site (clinic) registry.
ADARx Pharmaceuticals Content API
Press releases, publications and corporate pages.
ADARx Pharmaceuticals Embed API
oEmbed provider and SEO head rendering.
ADARx Pharmaceuticals Index API
Route discovery and site identity.
ADARx Pharmaceuticals Media API
The site media library.
ADARx Pharmaceuticals People API
Content authors registered on the site.
ADARx Pharmaceuticals Search API
Cross-content search.
ADARx Pharmaceuticals Taxonomy API
Categories, tags, taxonomies and post statuses.
Scroll for all 8
Semantic Vocabularies 1
JSON-LD contexts and semantic vocabularies used across these APIs.
Security Posture 2
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Get Started 1
Portal, sign-up, and the first successful call
Agent Surfaces 3
MCP servers, agent skills, and machine-readable catalogs
Design & Contract 6
Pagination, idempotency, versioning, errors, and events
Access & Security 2
Authentication, authorization, and security posture
Operate 2
Status, limits, changes, and where to get help
Commercial 2
Pricing, plans, and the legal terms of use
Company 7
The organization behind the API
Scroll for all 7
Other 10
Properties that don't map to a standard resource type
Scroll for all 10